"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
- Clinician Information:
Optiray Injection Patient Information including How Should I Take
In this Article
- What is ioversol (Optiray Injection)?
- What are the possible side effects of ioversol (Optiray Injection)?
- What is the most important information I should know about ioversol (Optiray Injection)?
- What should I discuss with my health care provider before receiving ioversol (Optiray Injection)?
- How is ioversol used (Optiray Injection)?
- What happens if I miss a dose (Optiray Injection)?
- What happens if I overdose (Optiray Injection)?
- What should I avoid while receiving ioversol (Optiray Injection)?
- What other drugs will affect ioversol (Optiray Injection)?
- Where can I get more information?
What should I discuss with my health care provider before receiving ioversol (Optiray Injection)?
Tell your doctor if you have ever had any type of reaction to another contrast agent.
You should not receive ioversol if you have any type of active infection.
Before receiving ioversol, tell your doctor if you have:
- a brain tumor or hematoma;
- a recent head or brain injury;
- epilepsy or other seizure disorder;
- a bleeding or blood clotting disorder;
- kidney disease;
- liver disease;
- heart disease, angina, or congestive heart failure;
- sickle cell disease;
- a history of stroke, blood clots, or circulation problems;
- asthma, hay fever, or a history of food or drug allergies;
- multiple myeloma (bone cancer);
- pheochromocytoma; or
- a thyroid disorder.
If you have any of these conditions, you may not be able to receive ioversol, or you may need a dosage adjustment or special tests during treatment.
FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
It is not known whether ioversol passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
Older adults may need special care in avoiding dehydration by drinking extra fluids before and after the radiologic test. Your kidney function may also need to be watched closely after you have received ioversol.
How is ioversol used (Optiray Injection)?
Ioversol is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting during your radiologic test.
Drink extra fluids before and after you receive ioversol. This medication can cause you to get dehydrated, which can lead to dangerous effects on your kidneys. Follow your doctor's instructions about the types and amount of fluids you should drink before and after your test.
Your doctor or other healthcare provider may want to watch you for a short period of time after your injection. This is to make sure you do not have any unwanted side effects or delayed reactions.
This medication can cause you to have unusual results with certain thyroid tests. If you have such tests within 16 days after receiving ioversol, tell the doctor in charge that you have recently received ioversol.
Additional Optiray Injection Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.